Caregiver Burden of Patients With Huntington's Disease in South Korea

Chan Young Lee1, Chaewon Shin2, Yun Su Hwang3,4

  • 1Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.

PubMed

Insights

Caregiver burden in Huntington's disease (HD) is significantly linked to patient's neurological status, not caregiver demographics. This highlights the need for tailored support systems for HD families in Korea.

Area of Science:

  • Neurology
  • Geriatrics
  • Psychiatry

Background:

  • Huntington's disease (HD) is a progressive neurodegenerative disorder.
  • Caregiver burden is a significant issue in chronic diseases.
  • Limited research exists on caregiver burden in HD within the Korean population.

Purpose of the Study:

  • To conduct the first prospective cohort study of Huntington's disease (HD) in Korea.
  • To investigate the relationship between caregiver burden and patient/caregiver characteristics in HD.

Main Methods:

  • Prospective cohort study involving 65 HD patients and 45 caregivers from 13 Korean university hospitals (August 2020 - February 2022).
  • Caregiver burden assessed using the 12-item Zarit Burden Interview (ZBI-12).
  • Linear regression analysis used to evaluate clinical associations with ZBI-12 scores and compare low- vs. high-burden groups.

Main Results:

  • The median ZBI-12 score was 17.6 ± 14.2.
  • Higher caregiver burden correlated with more severe Shoulson-Fahn stage (p=0.038), lower independence scale (B=-0.154, p=0.006), and reduced functional capacity (B=-1.082, p=0.002) in patients.
  • Longer caregiving duration was observed in the high-burden group; caregiver demographics, relation, marital, and social status did not significantly impact burden.

Conclusions:

  • Patient's neurological status is a primary driver of caregiver burden in HD, irrespective of caregiver demographics.
  • There is a critical need for optimized support systems for HD-affected families in Korea.
  • Longitudinal studies are recommended to understand how disease progression influences caregiver burden over time.
Abstract

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
916
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K